Biotech Acquisition (NASDAQ:BIOT) Short Interest Update

Biotech Acquisition (NASDAQ:BIOTGet Rating) was the target of a significant increase in short interest in the month of August. As of August 31st, there was short interest totalling 1,100 shares, an increase of 10.0% from the August 15th total of 1,000 shares. Based on an average daily volume of 123,500 shares, the days-to-cover ratio is presently 0.0 days.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. bought a new stake in Biotech Acquisition in the second quarter worth $19,966,000. Hudson Bay Capital Management LP boosted its stake in Biotech Acquisition by 147.5% in the 2nd quarter. Hudson Bay Capital Management LP now owns 1,261,609 shares of the company’s stock worth $12,490,000 after purchasing an additional 751,824 shares in the last quarter. Aristeia Capital LLC purchased a new stake in Biotech Acquisition during the 4th quarter valued at about $11,306,000. D. E. Shaw & Co. Inc. increased its stake in Biotech Acquisition by 75.4% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 929,085 shares of the company’s stock valued at $9,142,000 after purchasing an additional 399,255 shares in the last quarter. Finally, Omni Event Management Ltd raised its holdings in Biotech Acquisition by 25.4% in the first quarter. Omni Event Management Ltd now owns 844,965 shares of the company’s stock worth $8,331,000 after buying an additional 171,411 shares during the last quarter. Institutional investors own 86.02% of the company’s stock.

Biotech Acquisition Stock Performance

BIOT stock opened at $9.91 on Wednesday. The firm has a 50 day moving average price of $9.88 and a 200-day moving average price of $9.84. Biotech Acquisition has a 52-week low of $8.30 and a 52-week high of $10.41.

About Biotech Acquisition

(Get Rating)

Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

See Also

Receive News & Ratings for Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.